Pharmaceutical Research and Manufacturers of America (PhRMA)
Registered Principal Details
Business Or Interest:
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
Contact
KM
Kenneth McKay
670 Maine Ave SW, Suite 1000
Washington, DC 20024
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
670 Maine Ave SW, Suite 1000
Washington, DC 20024
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 62
Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)
Bill Text and History
4/17/2025
First Communication Date
4/2/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Oppose certain parts of the bill, neutral and supportive of other parts.
Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)
Bill Text and History
Against
Notification Date4/17/2025
First Communication Date
4/2/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Oppose certain parts of the bill, neutral and supportive of other parts.
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/17/2025
First Communication Date
4/9/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/17/2025
First Communication Date
4/9/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 50
Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)
Bill Text and History
4/17/2025
First Communication Date
4/2/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Oppose certain parts of the bill, neutral and supportive of other parts.
Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)
Bill Text and History
Against
Notification Date4/17/2025
First Communication Date
4/2/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Oppose certain parts of the bill, neutral and supportive of other parts.
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/17/2025
First Communication Date
4/17/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/17/2025
First Communication Date
4/17/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Insurance: Wisconsin Healthcare Stability Plan
Insurance: Wisconsin Healthcare Stability Plan
Notification Date
2/25/2025
First Communication Date
2/25/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
2/25/2025
First Communication Date
2/25/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Copay Accumulator programs including LRB 1278 and LRB 2364
Copay Accumulator programs including LRB 1278 and LRB 2364
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/12/2025
First Communication Date
3/3/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
3/12/2025
First Communication Date
3/3/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Access to Medications, including LRB 1302/1
Access to Medications, including LRB 1302/1
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/16/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/16/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/15/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/15/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Access to Medications
Access to Medications
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/29/2025
First Communication Date
1/7/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Total Lobbying Effort
| 2025 January - June |
Total | |
|---|---|---|
| Total Lobbying Expenditures | 2025 January - June $41,508.65 |
Total $41,508.65 |
| Total Hours Communicating | 2025 January - June 11.00 |
Total 11.00 |
| Total Hours Other | 2025 January - June 27.50 |
Total 27.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 17% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 18% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 43% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 44% |
Budget Bill Subjects
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 13% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 13% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 9% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 9% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication